Consistently, a study using human U266 multiple myeloma cell line showed that berberine treatment increased SET7/9 expression, promoted p65/RelA methylation, and suppressed p65/RelA-dependent transactivation of miR-21. Here, RELA is linked to plasma cell myeloma.